Novo Nordisk invests over USD 740m in Danish facility

The pharmaceutical firm is expanding its production facilities in Bagsværd, a Copenhagen suburb.
Photo: Stine Tidsvilde
Photo: Stine Tidsvilde
by andreas lønstrup, translated by catherine brett

Novo Nordisk plans to invest DKK 5.4bn (USD 744.4m) on expanding its existing facilities in Bagsværd, Greater Copenhagen, and construct a new building in extension of the existing site, the company writes in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading